The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The DOMUS study protocol : a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home. / Nordly, Mie; Benthien, Kirstine Skov; Von Der Maase, Hans; Johansen, Christoffer; Kruse, Marie; Timm, Helle Ussing; Vadstrup, Eva Soelberg; Kurita, Geana Paula; von Heymann-Horan, Annika Berglind; Sjøgren, Per.
In: B M C Palliative Care, Vol. 13, 2014, p. 44.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The DOMUS study protocol
T2 - a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home
AU - Nordly, Mie
AU - Benthien, Kirstine Skov
AU - Von Der Maase, Hans
AU - Johansen, Christoffer
AU - Kruse, Marie
AU - Timm, Helle Ussing
AU - Vadstrup, Eva Soelberg
AU - Kurita, Geana Paula
AU - von Heymann-Horan, Annika Berglind
AU - Sjøgren, Per
PY - 2014
Y1 - 2014
N2 - BACKGROUND: The focus of Specialized Palliative Care (SPC) is to improve care for patients with incurable diseases and their families, which includes the opportunity to make their own choice of place of care and ultimately place of death. The Danish Palliative Care Trial (DOMUS) aims to investigate whether an accelerated transition process from oncological treatment to continuing SPC at home for patients with incurable cancer results in more patients reaching their preferred place of care and death. The SPC in this trial is enriched with a manualized psychological intervention.METHODS/DESIGN: DOMUS is a controlled randomized clinical trial with a balanced parallel-group randomization (1:1). The planned sample size is 340 in- and outpatients treated at the Department of Oncology at Copenhagen University Hospital. Patients are randomly assigned either to: a) standard care plus SPC enriched with a standardized psychological intervention for patients and caregivers at home or b) standard care alone. Inclusion criteria are incurable cancer with no or limited antineoplastic treatment options.DISCUSSION: Programs that facilitate transition from hospital treatment to SPC at home for patients with incurable cancer can be a powerful tool to improve patients' quality of life and support family/caregivers during the disease trajectory. The present study offers a model for achieving optimal delivery of palliative care in the patient's preferred place of care and attempt to clarify challenges.TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT01885637.
AB - BACKGROUND: The focus of Specialized Palliative Care (SPC) is to improve care for patients with incurable diseases and their families, which includes the opportunity to make their own choice of place of care and ultimately place of death. The Danish Palliative Care Trial (DOMUS) aims to investigate whether an accelerated transition process from oncological treatment to continuing SPC at home for patients with incurable cancer results in more patients reaching their preferred place of care and death. The SPC in this trial is enriched with a manualized psychological intervention.METHODS/DESIGN: DOMUS is a controlled randomized clinical trial with a balanced parallel-group randomization (1:1). The planned sample size is 340 in- and outpatients treated at the Department of Oncology at Copenhagen University Hospital. Patients are randomly assigned either to: a) standard care plus SPC enriched with a standardized psychological intervention for patients and caregivers at home or b) standard care alone. Inclusion criteria are incurable cancer with no or limited antineoplastic treatment options.DISCUSSION: Programs that facilitate transition from hospital treatment to SPC at home for patients with incurable cancer can be a powerful tool to improve patients' quality of life and support family/caregivers during the disease trajectory. The present study offers a model for achieving optimal delivery of palliative care in the patient's preferred place of care and attempt to clarify challenges.TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT01885637.
U2 - 10.1186/1472-684X-13-44
DO - 10.1186/1472-684X-13-44
M3 - Journal article
C2 - 25242890
VL - 13
SP - 44
JO - BMC Palliative Care
JF - BMC Palliative Care
SN - 1472-684X
ER -
ID: 135649967